Insights

The best and worst performing ASX 200 healthcare shares of 2021

The pandemic hasn’t been a tailwind for many medical companies.
The post The best and worst performing ASX 200 healthcare shares of 2021 appeared first on The Motley Fool Australia. –

S&P/ASX 200 Index (ASX: XJO) healthcare shares have largely performed well in 2021.

Of the 13 companies categorised as ASX 200 healthcare shares, 10 are in the black for the calendar year while only 3 are showing losses.

Additionally, 7 of the 13 ASX 200 healthcare shares are beating the performance of the index, which has gained just under 13% year-to-date.

Below we take a look at the best and worst performer so far this year.

At the bottom of the 2021 list

The worst ASX 200 healthcare share performer so far in 2021 is Polynovo Ltd (ASX: PNV).

Year-to-date, Polynovo’s share price is down 44%. The medical device company is currently trading for $2.21 per share.

Polynovo hit turbulence early in the year when its half year financial results for the 6 months ending 31 December 2020, while showing sales growth, came in below guidance. Shares fell by 31% in January

COVID-19, a boon for some healthcare companies, has worked against this one.

The company depends on its access to surgeons and ongoing elective surgeries for growth. In May, shares suffered another sharp fall after the company reported a slowdown on both fronts due to the pandemic.

Top ASX 200 healthcare share performer in 2021

Coming in at the top of the list for ASX 200 healthcare shares in 2021 is Pro Medicus Limited (ASX: PME).

The healthcare imaging software and services provider’s share price is up 59% year-to-date, currently trading for $55.76.

Pro Medicus kicked off the New Year well, with the announcement of a major new contract win on 13 January for its Visage Imaging business.

The 7-year contract was signed with Intermountain Healthcare, the largest medical services provider in the US state of Utah. The company estimated the value of the contract at $40 million.

Pro Medicus shares gained 22% in January.

Shares enjoyed another boost in May with the announcement of another new contract win on 13 May. The 8-year deal with The University of Vermont Health Network in the US state of Vermont was valued at $14 million.

The company’s share’s price has gained 37% since it released that announcement.

The post The best and worst performing ASX 200 healthcare shares of 2021 appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

These are the 10 most shorted ASX shares

These are the 10 most shorted ASX shares

Pro Medicus (ASX:PME) share price tumbles 5% on broker downgrade
Why Fortescue, Over The Wire, Pro Medicus, & Whispir shares are dropping

ASX 200 midday update: Afterpay to be acquired by Square, Oil Search to merge with Santos

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended POLYNOVO FPO and Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!